MissionIR Articles
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Positioned to Compete in ‘Largely Untapped US Market’
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, recently completed a round of successful fundraising that will assist in expanding the availability of its platform. DarioHealth secured approximately $28.6…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Taking Health Care Home Through Innovative Platform
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, is a clear point-of-need innovator in today’s standoffish environment. The company supplies hospitals with next-generation technology to provide patients necessary care…
-
MissionIRNewsBreaks – Shares of DarioHealth Corp. (NASDAQ: DRIO) Reach 52-Week High
Shares of DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, reached a new 52-week high on Wednesday. In morning trading, the company’s shares reached a peak of $22.49 on volume of…
-
DarioHealth Corp. (NASDAQ: DRIO) Beats Street Q2 Revenue Estimates by 20% and Reveals Late Stage, Virtual Healthcare, B2B2C Sales Pipeline
DarioHealth Corp. reported its second quarter financial results Aug. 12, showing a revenue increase on a quarter-to-quarter basis, as well as gross profit increases of 95 percent and 60 percent on year-over-year quarterly and six-month…
-
MissionIRNewsBreaks – Aegis Capital Corp. Initiates Coverage, Issues ‘Buy’ Rating on DarioHealth Corp. (NASDAQ: DRIO)
Aegis Capital Corp. has initiated coverage with a ‘Buy’ rating and price target of $25 on shares of DarioHealth’s (NASDAQ: DRIO) stock. DRIO is a pioneer in the global digital therapeutics (“DTx”) industry with its…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q2 Revenue, Overview of Key Company Highlights and Development
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released a business update, including financial numbers and corporate achievements for the second quarter ended June 30, 2020. Highlights of the report include…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Featured in Fox Business Segment Regarding Telehealth and the Future
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, was featured in a Fox Business segment on Friday titled, “Is telehealth the future of health care?” Dariohealth CEO Erez Raphael joined Fox’s Liz…
-
MissionIRNewsBreaks – DarioHealth (NASDAQ: DRIO) Announces Plans to Release Q2 Financials, Provide Company Update
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, will release its second-quarter earnings on June 30, 2020, as well as host a 9 a.m. ET conference call and webcast on the same day. Hosted…
-
DarioHealth Corp. (NASDAQ: DRIO) Obtains Significant Capital Infusion with $28.6 Million Investment Round
DarioHealth Corp. is an digital therapeutics (“DTx”) pioneer supplying remote health condition monitoring technology to caregivers and their patients The company recently reported a successful private placement funding transaction that provides Dario with $28.6 million…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Rides Deal Wave to Stock Bump
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, is riding a wave that pushed its stock up 20% with no DRIO-related news. An article published to MarketWatch today titled, “UPDATE: Teladoc and…
-
DarioHealth Corp. (NASDAQ: DRIO) Platform Meets Patients’, Physicians’ Remote Care Needs Amid Pandemic
DarioHealth Corp. is a digital therapeutics innovator that supplies remote monitoring technology to caregivers and their patients The company’s Remote Patient Monitoring (“RPM”) technology reports patient data to care providers in the clinical setting and…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Deliver Best-In-Class RPM Solution Across the United Kingdom and Ireland
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, will begin serving Europeans with its health-monitoring solution through a strategic partnership with Williams Medical. Under the partnership, the DarioHealth Remote…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Provides Standout Solution for Digital Diabetes Management
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, was recently featured in a Data Bridge Market Research report. The piece highlighted DarioHealth’s advancements in digital diabetes management, a rapidly…
-
Digital Therapeutics Platform Builder DarioHealth Corp. (NASDAQ: DRIO) Makes International Leap with Williams Medical Partnership
DarioHealth Corp. is providing innovative solutions to medical patient care through its technology enabled remote patient monitoring platform (“RPM”), which it believes will save medical providers time while allowing them to better control care The…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters Strategic Agreement to Offer World-Class RPM Solution to HCPs Across the UK and Ireland
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced its entry into a new strategic partnership with Williams Medical to make the DarioHealth Remote Patient Monitoring (“RPM”) digital therapeutics platform available…
-
DarioHealth Corp. (NASDAQ: DRIO) Named Global Player in Digital Diabetes Management Market
The company was named to the list of BioSpace Movers and Shakers in July 2020 after veteran health plan executive Dennis A. Matheis joined its Board of Directors Global digital diabetes management market is projected…
-
MissionIRNewsBreaks – Why DarioHealth Corp. (NASDAQ: DRIO) Is ‘One to Watch’
DarioHealth (NASDAQ: DRIO) is a pioneer in the global digital therapeutics market focused on delivering evidence-based interventions to people with chronic conditions. A recent article discussing DarioHealth reads, “Patient engagement in therapies leads to health…
-
DarioHealth Corp. (NASDAQ: DRIO) is “One to Watch”
Dario’s popular (4.9 stars on the Apple App Store and 11,000 reviews) chronic condition management platform addresses a $72 billion annual U.S. market opportunity There are roughly 51,000 active users of the Dario platform, including…
Search Articles
Latest Articles
- Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ): Advancing a Premier North American Copper District
- MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) to Present at Emerging Growth Conference on August 20
- Safe Pro Group Inc. (NASDAQ: SPAI) Advanced AI Patent Protections with Notification Publications in Australia, Israel, and the European Region
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights Progress Across Lead Programs and Strategic Investment
- MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Prices $7 Million Public Offering of Common Stock and Pre-Funded Warrants